Public company intelligence preview
22ND CENTURY GROUP INC
18 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.
Snapshot
A narrow read on a much deeper workspace.
The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.
Insider compensation
Public aggregate: $903951.62 average total compensation across covered insiders.
Governance movement
Public aggregate: 1 governance events in the last year.
Institutional ownership
Public aggregate: 31 holders from the latest quarter.
Restricted sales and governance
Public counts, not the investigation layer.
The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.
Market context
Basic quote context for the preview.
Company note
Context before the data.
Company Overview
22nd Century Group Inc. is a Consumer Defensive company in the Tobacco industry that focuses on nicotine harm reduction through reduced-nicotine combustible products, led by its VLN® cigarettes. It also manufactures conventional cigarettes and filtered cigars for third parties through its vertically integrated facility in North Carolina, while expanding retail distribution and contract manufacturing relationships. Recent filings show the company is trying to shift away from lower-margin filtered cigars toward branded cigarettes, export sales, and VLN® rollouts, including broader convenience store placement. The business remains highly dependent on FDA authorizations, tax treatment, and other regulatory approvals, while operating under a capital-constrained environment.
Executive Compensation Practices
For a company like 22nd Century Group, executive compensation is likely to be heavily influenced by regulatory milestones, revenue growth, gross margin improvement, liquidity management, and successful commercialization of VLN® and contract manufacturing rather than simple top-line growth alone. In the tobacco sector, especially for a smaller player with ongoing going-concern risk, boards often emphasize retention tools such as equity awards, milestone-based bonuses, and performance incentives tied to product launches, store expansion, financing execution, and cost reductions. The filings suggest management has been focused on reducing SG&A, R&D, consulting, and legal costs, so compensation outcomes may also reflect success in preserving cash and improving operating leverage. Because the company depends on FDA-authorized products and capital raises, executives may have pay structures that reward regulatory progress and financing achievements as much as operating earnings.
Insider Trading Considerations
Insider trading patterns at 22nd Century Group may be especially sensitive to capital raises, product launch timing, FDA-related developments, and liquidity stress, all of which can materially move the stock. Since the company is small, volatile, and still reporting substantial doubt about continued operations, insiders may face heightened scrutiny around trades made near financing announcements, warrant exercises, asset sales, or regulatory updates. The tobacco industry’s heavy regulatory burden and the company’s reliance on VLN® commercialization and contract manufacturing also mean that insiders may have material nonpublic visibility into retail expansion, customer wins, and margin trends before they are publicly reflected. Researchers and traders should watch for clustered insider activity around financing events, debt repayments, partnership announcements, and rollout milestones, as these may be more informative than routine trading in a company with constrained liquidity and event-driven catalysts.
Unlock the full XXII insider intelligence workspace.
Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.